Matthew B Renfrow

Title: The Innovations of Matthew B. Renfrow

Introduction

Matthew B. Renfrow is an accomplished inventor based in Birmingham, AL (US). He has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of IgA nephropathy. His innovative approach has led to the development of methods that enhance the understanding and management of this condition.

Latest Patents

Renfrow holds a patent for "Diagnosing and treating IgA nephropathy." This patent outlines methods for diagnosing IgA nephropathy in a subject. The methods include isolating an IgG from the subject and determining whether the IgG binds to a galactose-deficient IgA1. Additionally, the methods involve providing a biological sample from the subject and detecting mutations in an IGH gene. These mutations are found in a nucleotide sequence encoding a complementarity determining region 3 (CDR3) of an IGH variable region. Furthermore, the methods also include determining the level of IgG specific for a galactose-deficient IgA1 in the subject. Renfrow's patent also provides methods for treating or reducing the risk of developing IgA nephropathy in a subject.

Career Highlights

Throughout his career, Renfrow has held prominent positions in various esteemed organizations. He served as the Chief of the Office of Research, Marketing & Policy Development at the Walter Reed Army Institute of Research. Additionally, he has worked with the UAB Research Foundation at The University of Alabama at Birmingham. His experience in these roles has contributed to his expertise in medical research and innovation.

Collaborations

Renfrow has collaborated with notable professionals in his field, including Yasuhiko Tomino and Hitoshi Suzuki. These collaborations have further enriched his research and development efforts.

Conclusion

Matthew B. Renfrow's contributions to the field of medical research, particularly in the diagnosis and treatment of IgA nephropathy, highlight his innovative spirit and dedication to improving patient outcomes. His work continues to influence the medical community and pave the way for future advancements.